Skip to main content
Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd. — Investor Relations & Filings

Ticker · 1099 ISIN · CNE100000FN7 LEI · 529900N54X78YH9JYK92 HKEX Wholesale and retail trade
Filings indexed 1,610 across all filing types
Latest filing 2023-07-06 Regulatory Filings
Country CN China
Listing HKEX 1099

About Sinopharm Group Co. Ltd.

http://www.sinopharmholding.com

Sinopharm Group Co. Ltd. is a major state-owned enterprise recognized as the largest pharmaceutical logistics provider in Asia and a leading distributor and retailer of healthcare products. The company's core business revolves around providing comprehensive medical supply chain services, encompassing the wholesale and retail distribution of pharmaceuticals, medical devices, and general healthcare products. Sinopharm serves a broad customer base, including hospitals, primary health service institutions, and retail pharmacies. Furthermore, the Group maintains an integrated ecosystem that extends beyond distribution into the manufacturing of pharmaceuticals and chemical reagents, medical services, and industry-finance integration, positioning it as a full-spectrum service provider in the healthcare sector.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return detailing movements in securities, specifically movements in authorised/registered share capital and issued shares for Sinopharm Group Co. Ltd. It includes confirmations related to securities issued during the month and compliance with listing rules on the Stock Exchange of Hong Kong. The document is structured as a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share issuance movements for the month ended 30 June 2023. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a report publication. It is a regulatory filing reporting share capital and share issuance movements, which fits best under the category of Regulatory Filings (RNS) as it does not match more specific categories like Share Issue/Capital Change (SHA) because it reports no changes in share capital or issued shares (all increases/decreases are zero). Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-07-06 English
List of Directors and Their Role and Function
Board/Management Information Classification · 95% confidence The document is an announcement listing the members of the board of directors and their roles and functions, including committee memberships. It does not contain financial data, earnings, or detailed reports. It is not a full annual report, audit report, or earnings release. It is not a call transcript or capital update. The document is focused on board composition and governance structure. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or information about the company's board of directors or senior management. The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2023-06-15 English
PROPOSED DISTRIBUTION OF FINAL DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Cash Dividend Announcement for Equity Issuer' and contains detailed information about the proposed distribution of a final dividend for the financial year ended 31 December 2022. It includes dividend amount, payment dates, withholding tax details, and record dates. There is no financial statement or comprehensive financial performance data, but rather an announcement related to dividend payment. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and details for shareholders. The document length is 6440 characters, which is sufficient for a detailed dividend announcement. Therefore, the appropriate classification is DIV.
2023-06-15 English
ANNOUNCEMENT POLL RESULTS OF THE ANNUAL GENERAL MEETING, THE H SHAREHOLDERS' CLASS MEETING AND THE DOMESTIC SHAREHOLDERS' CLASS MEETING HELD ON THURSDAY, 15 JUNE 2023 AND PAYMENT OF THE FINA
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement from Sinopharm Group Co. Ltd. detailing the poll results of the Annual General Meeting (AGM), the H Shareholders’ Class Meeting, and the Domestic Shareholders’ Class Meeting held on 15 June 2023. It includes detailed voting results on various resolutions such as approval of the board report, audited financial statements, profit distribution plan, appointment of auditors, and granting of mandates. It also announces the payment of the final dividend for the year ended 31 December 2022. The document is not the full annual report or financial statements but an official announcement of the voting results and dividend payment following the AGM. This fits the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length is substantial and contains detailed voting data, confirming it is not a brief report publication announcement or a regulatory filing. Therefore, the correct classification is DVA with high confidence.
2023-06-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return detailing movements in securities, specifically share capital and issued shares, for Sinopharm Group Co. Ltd. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content includes detailed tables of authorized and issued shares, confirmations by the company secretary, and notes on share movements. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory submission reporting share capital and share issuance movements for a specific month (May 2023). It is not a full annual or interim report, nor an earnings release or management report. It is a regulatory filing reporting share capital movements and confirmations to the exchange, fitting the category of Regulatory Filings (RNS). The document length (7164 characters) and detailed content support this classification rather than a brief announcement or report publication announcement.
2023-06-05 English
Notification Letter with Request Form to Non-Registered Shareholders
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 25 May 2023 from Sinopharm Group Co. Ltd. addressed to non-registered shareholders. It informs recipients about the publication of a circular dated 25 May 2023 and notices of the 2022 Annual General Meeting and H Shareholders' Class Meeting. The letter provides instructions on how shareholders can access the corporate communications online or request printed copies. It also includes a request form for shareholders to choose their preferred method of receiving future corporate communications. The document does not contain any financial statements, detailed financial data, or management discussion. It is essentially an announcement about the availability and distribution of corporate communications, including the AGM notices and circular, rather than the reports themselves. The document length is 8766 characters, which is relatively short and consistent with an announcement or notification letter rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA).
2023-05-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.